The pooled results demonstrated that high pre-treatment serum AFP-L3 levels significantly predicted poor OS and DFS for HCC (p<0.00001, p<0.00001, respectively), which may serve as an independent prognostic factor in patients with HCC. Here, AFP is linked to hepatocellular carcinoma.